Spectroswiss is a platform-capability provider developing advanced software and hardware solutions for mass spectrometry data acquisition, processing, and analysis.
Building on deep expertise in FTMS, we support both routine and advanced MS applications through proprietary technologies, expert consulting, training, and contract research services.
Our CRO offering combines high-performance Orbitrap™ mass spectrometry with expert scientific support to address analytical challenges in biotherapeutic discovery and development. We provide comprehensive characterization of monoclonal antibodies, antibody–drug conjugates, AAVs, and related complex biologics using integrated intact mass, middle-up, middle-/top-down, and bottom-up MS workflows.
We also apply Orbitrap™-based charge detection mass spectrometry (CDMS) to high-mass and heterogeneous assemblies, including intact and conjugated AAV capsids.
The company is headquartered in Lausanne, Switzerland